Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
Chesebro
J H
JH
Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Toschi
V
V
Lettino
M
M
Gallo
R
R
Badimon
J J
JJ
Fallon
J T
JT
Fuster
V
V
D000328:Adult; D017130:Angioplasty / Q000009:adverse effects; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D000990:Antithrombin III / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D003328:Coronary Thrombosis / Q000209:etiology / Q000628:therapy; D005342:Fibrinolysis; D006331:Heart Diseases / Q000209:etiology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011817:Rabbits; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000990:Antithrombin III; D013917:Thrombin; D001241:Aspirin